Silver Book Fact

Pregalbin, an antiepileptic drug, produced around a 32% pain reduction (a significant reduction) at week 16 versus around 20% for placebo, in patients with neuropathic pain due to spinal cord injury.

Cardenas D, Nieshoff E, Suda K, Goto S, et al. A Randomized Trial of Pregabalin in Patients with Neuropathic Pain due to Spinal Cord Injury. Neurology. 2013; 80(6): 533-9. http://www.neurology.org/content/early/2013/01/23/WNL.0b013e318281546b.abstract

Reference

Title
A Randomized Trial of Pregabalin in Patients with Neuropathic Pain due to Spinal Cord Injury
Publication
Neurology
Publication Date
2013
Authors
Cardenas D, Nieshoff E, Suda K, Goto S, et al.
Volume & Issue
Volume 80, Issue 6
Pages
533-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Topical NSAIDs were found in a meta-analysis to be significantly more effective than placebo in reducing persistent pain from musculoskeletal conditions.  
  • A meta-analysis of pscychological interventions for chronic low back pain found small but statistically significant effects for all interventions for as long as 5 years.  
  • Resolvins, a family of lipid mediators, have shown potential in resolving persistent inflammatory pain.  
  • Topical capsaicin was found in a meta-analysis to provide a degree of pain relief to some patients with painful neuropathic conditions.  
  • Pregalbin, an antiepileptic drug, produced around a 32% pain reduction (a significant reduction) at week 16 versus around 20% for placebo, in patients with neuropathic pain due to spinal cord…